Fennec Pharmaceuticals (NASDAQ:FENC) Price Target & New Coverage by Laidlaw

Laidlaw analyst has started coverage on Fennec Pharmaceuticals (NASDAQ:FENC) with a $22.0 target price per share and “Buy” rating. The target price per share would suggest a potential upside of 131.82 % from firm’s last close price.

Fennec Pharmaceuticals (NASDAQ:FENC) closed at $0 yesterday. A total of shares of the company’s stock traded hands. This is down from average of shares. Fennec Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0. The company has a market cap of $ and a P/E ratio of 0.

Get the latest Fennec Pharmaceuticals (NASDAQ:FENC) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Fennec Pharmaceuticals (NASDAQ:FENC) Coverage Started by Analysts at Laidlaw. The Firm’s Price Objective is $22.0 appeared first on Octafinance.